30 research outputs found
Notch-mediated cellular interactions between vascular cells.
Vessel formation and differentiation to a proper hierarchical vasculature requires a coordinated effort from endothelial and mural cells. Over the last decade Notch was identified as a key player in this process by promoting vascular arterialization and modulating endothelial tip-stalk phenotypes. Recent work has identified that Notch fine-tunes the diverse endothelial phenotypes through regulation of canonical cell-cycle and metabolism regulators, such as ERK and Myc. During arterialization, Notch signaling inhibits the cell-cycle and metabolism of endothelial cells which coincides with the acquisition of arterial identity. During angiogenesis, the same molecular machinery prevents the hypermitogenic arrest and excessive sprouting of vessels. Notch also signals in pericytes and smooth muscle cells promoting vascular coverage and maturation. Here, we will review the latest findings on how Notch signals regulate the differentiation and interactions among vascular cells during organ development and homeostasis.Rui Benedito’s laboratory was supported by the European Research
Council (ERC) Consolidator Grant AngioUnrestUHD (101001814), the
Ministerio de Ciencia e Innovacio´n (PID2020-120252RB-I00) and “la
Caixa” Banking Foundation (HR22-00316). Henar Cuervo’s research was
supported by the Atraccio´n de Talento funding from the Comunidad
Auto´noma de Madrid (2020-T1/BMD-19985).S
Role of Notch in endothelial biology.
The Notch signalling pathway is one of the main regulators of endothelial biology. In the last 20 years the critical function of
Notch has been uncovered in the context of angiogenesis, participating in tip-stalk specification, arterial-venous differentiation,
vessel stabilization, and maturation processes. Importantly, pharmacological compounds targeting distinct members
of the Notch signalling pathway have been used in the clinics for cancer therapy. However, the underlying mechanisms
that support the variety of outcomes triggered by Notch in apparently opposite contexts such as angiogenesis and vascular
homeostasis remain unknown. In recent years, advances in -omics technologies together with mosaic analysis and high
molecular, cellular and temporal resolution studies have allowed a better understanding of the mechanisms driven by the
Notch signalling pathway in different endothelial contexts. In this review we will focus on the main findings that revisit the
role of Notch signalling in vascular biology. We will also discuss potential future directions and technologies that will shed
light on the puzzling role of Notch during endothelial growth and homeostasis. Addressing these open questions may allow
the improvement and development of therapeutic strategies based on modulation of the Notch signalling pathway.pre-print1.454 K
Endothelial sprouting, proliferation, or senescence: tipping the balance from physiology to pathology.
Therapeutic modulation of vascular cell proliferation and migration is essential for the effective inhibition of angiogenesis in cancer or its induction in cardiovascular disease. The general view is that an increase in vascular growth factor levels or mitogenic stimulation is beneficial for angiogenesis, since it leads to an increase in both endothelial proliferation and sprouting. However, several recent studies showed that an increase in mitogenic stimuli can also lead to the arrest of angiogenesis. This is due to the existence of intrinsic signaling feedback loops and cell cycle checkpoints that work in synchrony to maintain a balance between endothelial proliferation and sprouting. This balance is tightly and effectively regulated during tissue growth and is often deregulated or impaired in disease. Most therapeutic strategies used so far to promote vascular growth simply increase mitogenic stimuli, without taking into account its deleterious effects on this balance and on vascular cells. Here, we review the main findings on the mechanisms controlling physiological vascular sprouting, proliferation, and senescence and how those mechanisms are often deregulated in acquired or congenital cardiovascular disease leading to a diverse range of pathologies. We also discuss alternative approaches to increase the effectiveness of pro-angiogenic therapies in cardiovascular regenerative medicine.Severin Mühleder was funded by the Austrian Science Fund (FWF) project J4358. Macarena Fernández-Chacón and Irene Garcia-Gonzalez were supported by PhD fellowships from Fundación La Caixa (CX_E-2015-01 and CX-SO-16-1, respectively). Rui Benedito was funded by the European Research Council (ERC-2014-StG—638028), the Centro Nacional de Investigaciones Cardiovasculares (CNIC), and by the Ministerio de Economia, Industria y Competitividad (MEIC: SAF2013-44329-P, SAF2017-89299-P, and RYC-2013-13209). The CNIC is supported by the Ministerio de Ciencia, Innovación y Universidades (MCNU) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505).S
Endothelial Extracellular Vesicles—Promises and Challenges
Extracellular vesicles, including exosomes, microparticles, and apoptotic bodies, are phospholipid bilayer-enclosed vesicles that have once been considered as cell debris lacking biological functions. However, they have recently gained immense interest in the scientific community due to their role in intercellular communication, immunity, tissue regeneration as well as in the onset, and progression of various pathologic conditions. Extracellular vesicles of endothelial origin have been found to play a versatile role in the human body, since they are on the one hand known to contribute to cardiovascular diseases, but on the other hand have also been reported to promote endothelial cell survival. Hence, endothelial extracellular vesicles hold promising therapeutic potential to be used as a new tool to detect as well as treat a great number of diseases. This calls for clinically approved, standardized, and efficient isolation and characterization protocols to harvest and purify endothelial extracellular vesicles. However, such methods and techniques to fulfill stringent requirements for clinical trials have yet to be developed or are not harmonized internationally. In this review, recent advances and challenges in the field of endothelial extracellular vesicle research are discussed and current problems and limitations regarding isolation and characterization are pointed out
Fluorescence-Based Nanoparticle Tracking Analysis and Flow Cytometry for Characterization of Endothelial Extracellular Vesicle Release.
As extracellular vesicles (EVs) have become a prominent topic in life sciences, a growing number of studies are published on a regular basis addressing their biological relevance and possible applications. Nevertheless, the fundamental question of the true vesicular nature as well as possible influences on the EV secretion behavior have often been not adequately addressed. Furthermore, research regarding endothelial cell-derived EVs (EndoEVs) often focused on the large vesicular fractions comprising of microvesicles (MV) and apoptotic bodies. In this study we aimed to further extend the current knowledge of the influence of pre-isolation conditions, such as cell density and conditioning time, on EndoEV release from human umbilical vein endothelial cells (HUVECs). We combined fluorescence nanoparticle tracking analysis (NTA) and the established fluorescence-triggered flow cytometry (FT-FC) protocol to allow vesicle-specific detection and characterization of size and surface markers. We found significant effects of cell density and conditioning time on both abundance and size distribution of EndoEVs. Additionally, we present detailed information regarding the surface marker display on EVs from different fractions and size ranges. Our data provide crucial relevance for future projects aiming to elucidate EV secretion behavior of endothelial cells. Moreover, we show that the influence of different conditioning parameters on the nature of EndoEVs has to be considered.This research was funded by the Austrian Research promotion agency and Particle Metrix. Severin Mühleder was funded by the Austrian Science Fund (FWF) project J4358.S
Engineering Blood and Lymphatic Microvascular Networks in Fibrin Matrices
Vascular network engineering is essential for nutrient delivery to tissue-engineered constructs and, consequently, their survival. In addition, the functionality of tissues also depends on tissue drainage and immune cell accessibility, which are the main functions of the lymphatic system. Engineering both the blood and lymphatic microvasculature would advance the survival and functionality of tissue-engineered constructs. The aim of this study was to isolate pure populations of lymphatic endothelial cells (LEC) and blood vascular endothelial cells (BEC) from human dermal microvascular endothelial cells and to study their network formation in our previously described coculture model with adipose-derived stromal cells (ASC) in fibrin scaffolds. We could follow the network development over a period of 4 weeks by fluorescently labeling the cells. We show that LEC and BEC form separate networks, which are morphologically distinguishable and sustainable over several weeks. In addition, lymphatic network development was dependent on vascular endothelial growth factor (VEGF)-C, resulting in denser networks with increasing VEGF-C concentration. Finally, we confirm the necessity of cell–cell contact between endothelial cells and ASC for the formation of both blood and lymphatic microvascular networks. This model represents a valuable platform for in vitro drug testing and for the future in vivo studies on lymphatic and blood microvascularization
Microvascular Networks From Endothelial Cells and Mesenchymal Stromal Cells From Adipose Tissue and Bone Marrow: A Comparison
A promising approach to overcome hypoxic conditions in tissue engineered constructs is to use the potential of endothelial cells (EC) to form networks in vitro when co-cultured with a supporting cell type in a 3D environment. Adipose tissue-derived stromal cells (ASC) as well as bone marrow-derived stromal cells (BMSC) have been shown to support vessel formation of EC in vitro, but only very few studies compared the angiogenic potential of both cell types using the same model. Here, we aimed at investigating the ability of ASC and BMSC to induce network formation of EC in a co-culture model in fibrin. While vascular structures of BMSC and EC remained stable over the course of 3 weeks, ASC-EC co-cultures developed more junctions and higher network density within the same time frame. Both co-cultures showed positive staining for neural glial antigen 2 (NG2) and basal lamina proteins. This indicates that vessels matured and were surrounded by perivascular cells as well as matrix molecules involved in stabilization. Gene expression analysis revealed a significant increase of vascular endothelial growth factor (VEGF) expression in ASC-EC co-culture compared to BMSC-EC co-culture. These observations were donor-independent and highlight the importance of organotypic cell sources for vascular tissue engineering
Fabrication of biomimetic placental barrier structures within a microfluidic device utilizing two-photon polymerization
The placenta is a transient organ, essential for development and survival of the unborn fetus. It interfaces the body of the pregnant woman with the unborn child and secures transport of endogenous and exogenous substances. Maternal and fetal blood are thereby separated at any time, by the so-called placental barrier. Current in vitro approaches fail to model this multifaceted structure, therefore research in the field of placental biology is particularly challenging. The present study aimed at establishing a novel model, simulating placental transport and its implications on development, in a versatile but reproducible way. The basal membrane was replicated using a gelatin-based material, closely mimicking the composition and properties of the natural extracellular matrix. The microstructure was produced by using a high-resolution 3D printing method - the two-photon polymerization (2PP). In order to structure gelatin by 2PP, its primary amines and carboxylic acids are modified with methacrylamides and methacrylates (GelMOD-AEMA), respectively. High-resolution structures in the range of a few micrometers were produced within the intersection of a customized microfluidic device, separating the x-shaped chamber into two isolated cell culture compartments. Human umbilical-vein endothelial cells (HUVEC) seeded on one side of this membrane simulate the fetal compartment while human choriocarcinoma cells, isolated from placental tissue (BeWo B30) mimic the maternal syncytium. This barrier model in combination with native flow profiles can be used to mimic the microenvironment of the placenta, investigating different pharmaceutical, clinical and biological scenarios. As proof-of-principle, this bioengineered placental barrier was used for the investigation of transcellular transport processes. While high molecular weight substances did not permeate, smaller molecules in the size of glucose were able to diffuse through the barrier in a time-depended manner. We envision to apply this bioengineered placental barrier for pathophysiological research, where altered nutrient transport is associated with health risks for the fetus
Engineering of three-dimensional pre-vascular networks within fibrin hydrogel constructs by microfluidic control over reciprocal cell signaling
This article may be downloaded for personal use only. Any other use requires prior permission of the author and AIP Publishing. The following article appeared in B. Bachmann et. al., Biomicrofluidics 12, 042216 (2018) and may be found at https://doi.org/10.1063/1.5027054
Incongruence between transcriptional and vascular pathophysiological cell states
Research in R.B.’s laboratory was supported by the European Research
Council Starting Grant AngioGenesHD (638028) and Consolidator
Grant AngioUnrestUHD (101001814), the CNIC Intramural Grant
Program Severo Ochoa (11-2016-IGP-SEV-2015-0505), the Ministerio
de Ciencia e Innovación (MCIN) (SAF2013-44329-P, RYC-2013-
13209, and SAF2017-89299-P) and ‘La Caixa’ Banking Foundation
(HR19-00120). J.V.’s laboratory was supported by MCIN (PGC2018-
097019-B-I00 and PID2021-122348NB-I00) and La Caixa (HR17-00247
and HR22-00253). K.G.’s laboratory was supported by Knut and
Alice Wallenberg Foundation (2020.0057) and Vetenskapsrådet
(2021-04896). The CNIC is supported by Instituto de Salud Carlos
III, MCIN, and the Pro CNIC Foundation, and is a Severo Ochoa
Center of Excellence (grant CEX2020-001041-S funded by MCIN/
AEI/10.13039/501100011033). Microscopy experiments were
performed at the Microscopy and Dynamic Imaging Unit, CNIC,
ICTS-ReDib, co-funded by MCIN/AEI/10.13039/501100011033 and
FEDER ‘Una manera de hacer Europa’ (ICTS-2018-04-CNIC-16). M.F.-C.
was supported by PhD fellowships from La Caixa (CX_E-2015-01)
and Boehringer Ingelheim travel grants. S.M. was supported by the
Austrian Science Fund (J4358). A.R. was supported by the Youth
Employment Initiative (PEJD-2019-PRE/BMD-16990). L.G.-O. was
supported by the Spanish Ministry of Economy and Competitiveness
(PRE2018-085283). We thank S. Bartlett (CNIC) for English editing,
as well as the members of the Transgenesis, Microscopy, Genomics,
Citometry and Bioinformatic units at CNIC. We also thank F. Radtke
(Swiss Institute for Experimental Cancer Research), R. H. Adams (Max
Planck Institute for Molecular Biomedicine), F. Alt (Boston Children’s
Hospital, Harvard Medical School), T. Honjo (Kyoto University Institute
for Advanced Studies), I. Flores (CNIC), J. Lewis (Cancer Research
UK London Research Institute), S. Habu (Tokai University School of
Medicine), T. Gridley (Maine Health Institute for Research) and C.
Brakebusch (Biotech Research and Innovation Centre) for sharing the
Dll4floxed, Notch1floxed, Notch2floxed, Cdh5(PAC)-creERT2, Myc floxed,
Rbpj floxed, p21−/−, Jag1floxed, Dll1floxed, Jag2floxed and Rac1floxed mice.S